You are here

chronic immune thrombocytopenia

FDA adds rare bleeding risk to J&J shot side effects

Beckers Hospital Review

Thu, 01/13/22 - 07:26 am

chronic immune thrombocytopenia

Rilzabrutinib granted FDA fast track designation for treatment of immune thrombocytopenia

Pharmaceutical Business Review

Thu, 11/19/20 - 10:40 am

Principia Biopharma

chronic immune thrombocytopenia

FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults

CP Wire

Wed, 04/18/18 - 11:31 am

Rigel Pharmaceuticals

chronic immune thrombocytopenia

FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults

Wed, 04/18/18 - 12:13 am

Rigel Pharmaceuticals

chronic immune thrombocytopenia

FDA Grants Expanded Use of Promacta for Novartis

Yahoo/24-7 Wall St

Tue, 08/25/15 - 08:30 am

chronic immune thrombocytopenia